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Abstract: Sodium selenate is a common ingredient in nutraceuticals/pharmaceuticals as a source of selenium. The objective 
of the current study was to evaluate the impact of The Trivedi Effect® - Energy of Consciousness (Biofield Energy Healing) on 
the physicochemical, spectral, and thermal properties of The Trivedi Effect® Treated sodium selenate using various analytical 
methods such as PXRD, PSD, FT-IR, UV-vis, DSC, and TGA. Sodium selenate was divided into two parts. One part was 
denoted as the control, while the other part was defined as The Trivedi Effect® - Biofield Energy Treated sample, which 
received The Trivedi Effect® Treatment remotely from eighteen renowned Biofield Energy Healers. The PXRD analysis of the 
treated sample showed the significant alteration of the crystallite size in the range of -16.63% to 42.9% compared with the 
control sample. However, the average crystallite size of the treated sodium selenate was increased by 1.01% compared with the 
control sample. The particle sizes d10, d50, and d90 values of the treated sample were significantly decreased by 6.14%, 16.56%, 
and 18.82%, respectively compared with the control sample. Consequently, the surface area of the treated sample was 
significantly increased by 10.52% compared with the control sample. Both control and treated FT-IR spectra indicated the 
presence of sharp and strong absorption bands at 888 and 887 cm-1, respectively due to the Se=O stretching. The UV-vis 
spectroscopic analysis displayed that the wavelength for the maximum absorbance of the control and treated sodium selenate 
were at 204.8 and 204.9 nm, respectively. The TGA of the control and treated samples exhibited two steps of thermal 
degradation, and the total weight loss was slightly increased by 1.16% in the treated sample compared with the control sample. 
The DSC thermograms showed the latent heat of fusion (∆H) was significantly elevated by 6.37% in the treated sample 
compared with the control sample. The current study revealed that The Trivedi Effect® - Energy of Consciousness (Biofield 
Energy Healing) might generate a new polymorphic form of sodium selenate which could be more soluble, thermally more 
stable, and higher absorption rate compared with the untreated sample. Hence, The Trivedi Effect® treated sodium selenate 
would be very useful to design the various forms of nutraceuticals and/or pharmaceutical formulation which might be 
providing a better therapeutic response against heart disease (i. e. Atherosclerosis), viral diseases (i. e. Hepatitis), infectious 
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diseases (i. e. Dermatitis, Psoriasis), Parkinson’s Disease, Alzheimer’s Disease, etc. 
Keywords: Biofield Energy Healing Treatment, Biofield Energy Healers, Consciousness Energy Healing,  
The Trivedi Effect®, Sodium Selenate, PXRD, Particle Size, FT-IR, UV-vis, DSC, TGA 
 
1. Introduction 
Sodium selenate (Na2SeO4) is an important source of an 
essential trace element selenium (Se) for the human body. 
Selenium plays an important role in various biological 
functions such as the catalytic effect on the reaction of 
metabolic intermediates and inhibits the toxic effect of heavy 
metals. Selenium is present in the active site of enzymes like 
glutathione peroxidase and thirty different proteins like 
selenocysteine. It is a potent antioxidant and is involved in 
the cellular defense against the free radicals [1, 2]. Therefore, 
the deficiency of selenium produces several disorders such as 
heart disease, viral diseases, infectious diseases, degenerative 
ailments, etc. As there is a very restricted range between 
essentiality and toxicity, a little bit high concentration of 
selenium can affect the human health such as loosing of hair 
and nails, irritation of skin and eye, cancer, giddiness, 
depression, and nervousness [1-3]. The activities of selenium 
depend upon numerous physicochemical and biological 
factors, as these factors are related to the modifications in its 
oxidation state. It occurs naturally in four different oxidation 
states, i. e. -2, 0, +4, and +6. The different chemical forms of 
selenium can impact on its solubility and bioavailability to 
the organisms. Selenate is a most oxidized form of the 
selenium compounds. It is less toxic and highly soluble in 
water [1-5]. Sodium selenate is useful for the prevention and 
treatment of various ailments such as Alzheimer’s disease, 
diabetes, etc. [6-8]. It is also used in the glass industry [9], an 
ingredient in some insecticides (against mites, aphids, and 
mealybugs) and some fungicides [10, 11]. It can be used with 
vitamin E in the prevention of a many nutritional deficiency 
diseases [1]. Selenium methionine is a naturally occurring 
amino acid and is also the major nutritional source of 
selenium for the human body. After absorption in the body, 
inorganic forms of selenium undergo reductive metabolism 
giving H2Se, which is responsible for the production of 
selenoproteins [12]. Hence, sodium selenate is used as one of 
the constituents in a new proprietary herbomineral 
formulation as supplement of selenium ion along with the 
ashwagandha root extract and other essential minerals such 
as zinc and magnesium, which are commonly used as 
nutraceuticals for the prevention and treatment of various 
disorders. 
The human being can emit the electromagnetic waves in 
the form of bio-photons that surrounds the body. This 
electromagnetic field is generated from the continuous 
movement of the electrically charged particles inside the 
body. This is collectively known as Biofield. Biofield Energy 
Healing Practitioners have the ability to harness the energy 
from the environment or the “universal energy field”, and 
that can be transmitted into any living or non-living 
substance (s) around the earth. The process by which the 
substance receives the Biofield Energy Treatment and 
responds in a useful way is known as Biofield Energy 
Healing [13-15]. 
Biofield (putative energy fields) based energy therapies are 
used to promote health and are practiced worldwide. The 
National Center of Complementary and Integrative Health 
(NCCIH) has recognized and accepted Biofield Energy 
Healing as a complementary and alternative medicine (CAM) 
health care approach in addition to other therapies, medicines 
and practices such as natural products, deep breathing, yoga, 
Tai Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, 
movement therapy, pilates, rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki, cranial sacral therapy and applied prayer (as is 
common in all religions, like Christianity, Hinduism, 
Buddhism and Judaism) [16]. Scientific study on the various 
fields such as materials science [17-19], pharmaceuticals [20-
22], nutraceuticals [23, 24], organic compounds [25-27], 
microbiology [28-30], agricultural [31, 32], biotechnology 
[33-35], genetics [36, 37], medical sciences [38, 39], has 
been proven that Biofield Energy Healing (The Trivedi 
Effect®) has the astounding capability for the alteration of the 
characteristic properties of the living and non-living 
substances. Scientific literature reported that the 
bioavailability of inorganic selenium is lower than the 
organic forms of selenium such as selenium methionine. But, 
selenium methionine is easily oxidized to methionine 
selenoxide, which is poorly absorbed from the gut of the 
human body [12]. The physicochemical properties such as 
crystalline structure, crystallite size, particle size, surface 
area, etc. of a drug molecule play an important role in 
bioavailability as these factors have the direct influence on 
the absorption characteristic and stability of the drug [40]. 
The stability of a solid pharmaceutical with respect to the 
atmospheric conditions is very important to the 
pharmaceutical industry, due to the practical involvements of 
hydrate formation upon processing, formulation, storage, and 
packaging [41]. Biofield Energy Treatment (The Trivedi 
Effect®) has been reported to change the particle size, surface 
area, crystallite size, spectral and thermal behaviour of an 
atom/molecule through the possible mediation of neutrinos 
[42]. Hence, the objective of the current study was to 
evaluate the effect of the Biofield Energy Healing Treatment 
on the physicochemical, spectral, and thermal properties of 
sodium selenate using various analytical techniques include 
powder X-ray diffraction (PXRD), particle size distribution 
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analysis (PSD), Fourier transform infrared (FT-IR) 
spectrometry, ultraviolet-visible (UV-vis) spectroscopy, 
thermogravimetric analysis (TGA), and differential scanning 
calorimetry (DSC). 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Sodium selenate was procured from Alfa Aesar, USA. All 
other chemicals used in the experiment were of analytical 
grade available in India. 
2.2. Energy of Consciousness Healing Treatment Strategies 
Sodium selenate was one of the components of the 
herbomineral formulation, and it was used independently for 
the current analysis. One part of the test compound was 
treated with the Biofield Energy (The Trivedi Effect®) by 
renowned Biofield Energy Healers and defined as The 
Trivedi Effect® - Energy of Consciousness Healing Treated 
sodium selenate, while the second part of the compound did 
not receive any sort of treatment and defined as untreated or 
control sodium selenate. This The Trivedi Effect® treatment 
was provided through a group of eighteen renowned Biofield 
Energy Healers who participated in this study and performed 
The Trivedi Effect® - Energy of Consciousness Healing 
Treatment remotely to the test compound. Eleven of the 
Biofield Energy Healers were located in the U. S. A., four in 
Canada, one in Ireland, one in the United Kingdom, and one 
in Russia performed the Biofield Energy Treatment on the 
test compound that was located in the research laboratory of 
GVK Biosciences Pvt. Ltd., Hyderabad, India. The Trivedi 
Effect® treatment was provided for 5 minutes through the 
Healer’s Unique Energy Transmission process remotely to 
the test compound under the laboratory conditions. None of 
the Biofield Energy Healers in this study visited the 
laboratory in person, nor had any contact with the test 
sample. Similarly, the control compound was subjected to 
“sham” healers for 5 minutes, under the same laboratory 
conditions. The sham healer did not have any knowledge 
about The Trivedi Effect® - Energy of Consciousness Healing 
Treatment. After that, the treated and untreated samples were 
kept in similar sealed conditions were characterized 
thoroughly by PXRD, PSD, FT-IR, UV-visible spectroscopy, 
TGA, and DSC analysis. 
2.3. Characterization 
2.3.1. Powder X-ray Diffraction (PXRD) Analysis 
The PXRD analysis was accomplished on PANalytical 
X’pert Pro powder X-ray diffractometer system. The X-ray 
of wavelength 1.54056 Å was used. The data was collected in 
the form of a chart of the Bragg angle (2θ) vs. intensity, and a 
detailed table containing information on peak intensity 
counts, d value (Å), relative intensity (%), full width half 
maximum (FWHM) (θ°). From the XRD results, the 
crystallite size (G) was calculated using X’pert data collector 
and X’pert high score plus processing software. 
The average crystallite size (G) was calculated from the 
Scherrer equation (Eq. 1) given below [43, 44]. The method 
was based on the width of the diffraction patterns obtained in 
the X-ray reflected the crystalline region. 
G = kλ/ (bCosθ)                            (1) 
Where, k is the equipment constant (0.5), λ is the X-ray 
wavelength (0.154 nm); b in radians is the full-width at half 
of the peaks and θ the corresponding Bragg angle. 
Percent change in crystallite size (G) was calculated using 
the following equation 2: 
%	change	in	crystallite	size =


× 100  (2) 
Where, Gcontrol and Gtreated denote the crystallite size of the 
control and treated powder samples, respectively. 
2.3.2. Particle Size Distribution (PSD) Analysis 
The average particle size and particle size distribution 
were analyzed using Malvern Mastersizer 2000, UK with a 
detection range between 0.01 µm to 3000 µm. The sample 
unit was filled with dispersant medium and operated the 
stirrer at 2500 rpm. Alignment of the optics was done and 
taken the background measurement. After the background 
measurement, the sample was added to the sample unit with 
constant monitoring the obscuration and stopped the addition 
of sample when the obscuration reached in between 15% and 
20%. When the obscuration was stable, the measurement was 
taken twice and the average was taken of two measurements. 
The average histogram of the two measurements was 
recorded. The print out of the average histogram of the two 
measurements will be documented. Along with histogram, 
the data will be presented in the table format which include 
particle size (µm). Also, the values at below 10% level (d10), 
50% level (d50), and 90% level (d90) were calculated from the 
histogram and the calculations such as surface area (m2/g) 
were done by using software Mastersizer 2000. Percent 
change in particle size (d) for at below 10% level (d10), 50% 
level (d50), and 90% level (d90) was calculated using 
following equation 3: 
%	change	in	particle	size =
##
#
× 100	   (3) 
Where, dControl and dTreated are the particle size (µm) for at 
below 10% level (d10), 50% level (d50), and 90% level (d90) 
of the control and treated samples, respectively. 
Percent change in surface area (S) was calculated using 
following equation 4: 
%	change	in	surface	area =
&&
&
× 100  (4) 
Where, SControl and STreated are the surface area of the 
control and treated samples, respectively. 
2.3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
FT-IR spectroscopy of sodium selenate was performed on 
Spectrum two (Perkin Elmer, USA) Fourier transform 
infrared spectrometer with the frequency array of 400-4000 
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cm-1 by using pressed KBr disk technique. 
2.3.4. Ultra Violet-Visible (UV-Vis) Spectroscopy 
The UV-Vis spectral analysis was carried out using 
Shimadzu UV-2450 with UV Probe, Japan. The spectrum 
was recorded using 1. cm quartz cell that has a slit width of 
1.0nm. The wavelength range chosen for recording the 
spectra was 190-800 nm. The absorbance spectra (in the 
range of 0.2 to 0.9) and wavelength of maximum absorbance 
(λmax) were recorded. 
2.3.5. Thermal Gravimetric Analysis (TGA) 
The analysis was performed using Instrument TGA Q50 
(TA Instruments, USA) thermo gravimetric analysis at a 
heating rate of 10°C/min from room temperature i.e. 30°C to 
900°C under the nitrogen atmosphere, 11.86 mg of samples 
were taken on the Platinum pan. In TGA, the weight loss for 
each step was recorded in grams as well as in percent loss 
with respect to the initial weight. Also, the onset, endset, and 
peak temperature for each step were recorded in TGA. 
Percent change in weight loss (W) was calculated using 
following equation 5: 
%	change	in	weight	loss 
)	)	
)	
 100      (5) 
Where, WControl and WTreated are the weight loss of the 
control and treated samples, respectively. 
2.3.6. Differential Scanning Calorimetry (DSC) 
The analysis was performed using the DSC Q20 (TA 
Instruments, USA) differential scanning calorimeter.2.70 mg 
of sample was weighed and sealed in aluminium pans and 
equilibrated at 25°C and heated up to 600°C at the heating 
rate of 10°C/min under nitrogen gas as purge atmosphere 
with the flow rate of 50 mL/min. The value for onset, endset, 
peak temperature, peak height (mJ or mW), peak area, and 
change in heat (J/g) for each peak was recorded. Percent 
change in melting point (T) was calculated using following 
equation 6: 
%	change	in	melting	point 
++
+
 100      (6) 
Where, TControl and TTreated are the melting point of the 
control and treated samples, respectively. 
Percent change in latent heat of fusion (∆H) was calculated 
using following equation 7: 
%	change	in	Latent	heat	of	fusion 
-.-.
-.
 100	     (7) 
Where, ∆HControl and ∆HTreated are the latent heat of fusion 
of the control and treated samples, respectively. 
3. Results and Discussion 
3.1. Powder X-Ray Diffraction (PXRD) Analysis 
Powder X-ray diffraction analysis was conducted to 
analyse the crystalline pattern of the control and treated 
samples of sodium selenate (Figure 1 and Table 1). 
Diffractogram of the control sodium selenate showed the 
peaks at Bragg’s angle (2θ) equal to 18.51°, 22.62°, 27.38°, 
28.50°, 31.14°, 32.74°, 34.41°, 37.33°, 45.18°, 46.01, 47.49°, 
and 48.92°. Similarly, the diffractogram of the treated 
sodium selenate exhibited the peaks at 2θ equal to 18.64°, 
22.75°, 27.51°, 28.63°, 31.27°, 32.87°, 34.53°, 37.46°, 
45.30°, 46.13, 47.61°, and 49.04°. The PXRD diffractograms 
showed the sharp and intense peaks in both the samples and 
no broadening of peaks were evident, which indicated that 
both the samples were crystalline in nature. However, the 
diffractogram of the treated sodium selenate showed the 
peaks with increased intensity compared with the control 
sample (Table 1). 
 
Figure 1. PXRD diffractograms of the control and Biofield Energy Treated sodium selenate. 
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Table 1. PXRD data for the control and Biofield Energy Treated sodium selenate.  
Entry no 
Bragg angle (°2θ) Relative Intensity (%) FWHM (°2θ) Crystallite size (G, nm) 
Control Treated  Control Treated  Control Treated  Control Treated  % changea 
1 18.51 18.64 100.00 100.00 0.1004 0.1171 44.42 38.09 -14.25 
2 22.62 22.75 23.26 20.12 0.1338 0.1338 33.55 33.56 0.03 
3 27.38 27.51 52.13 48.58 0.1171 0.1338 38.69 33.87 -12.46 
4 28.50 28.63 31.81 30.69 0.1004 0.1171 45.24 38.80 -14.24 
5 31.14 31.27 73.67 68.97 0.1338 0.1171 34.16 39.04 14.29 
6 32.74 32.87 67.59 71.83 0.1338 0.1004 34.29 45.72 33.33 
7 34.41 34.53 6.92 6.52 0.1338 0.1338 34.45 34.46 0.03 
8 37.33 37.46 21.10 21.92 0.1506 0.1338 30.86 34.75 12.61 
9 45.18 45.30 7.89 6.10 0.1673 0.2007 28.51 23.77 -16.63 
10 46.01 46.13 6.16 5.53 0.1673 0.1171 28.60 40.87 42.90 
11 47.49 47.61 27.10 21.59 0.1004 0.1004 47.92 47.94 0.04 
12 48.92 49.05 13.38 13.01 0.1224 0.1428 39.53 33.90 -14.24 
13 Average crystallite size 36.69 37.06 1.01 
FMHM: Full width at half maximum, a denotes the percentage in the crystallite size of Biofield Energy Treated sample with respect to the control sample. 
The most intense peaks were observed at 2θ equal to 
18.51° and 18.64° in the control and treated diffractograms, 
respectively (Table 1, entry 1). It indicated that the relative 
intensities of PXRD peaks were altered in the treated sodium 
selenate compared with the control sample. The changes in 
crystal morphology cause the alteration in relative intensities 
of the peaks [44]. Thus, it is presumed that the energy 
transferred through The Trivedi Effect® - Biofield Energy 
Treatment probably altered the shape and size of molecules 
of the treated sample and that might be responsible for the 
alteration in relative intensities in the treated sample 
compared with the control sample. The average crystallite 
size was calculated using Scherrer equation [43]. The PXRD 
analysis of the treated sample showed the significant 
alteration of the crystallite size in the range of -16.63% to 
42.90% compared with the control sample. The crystallite 
size of the treated zinc chloride at 2θ equal to nearly 18.64°, 
27.51°, 28.63°, 45.30° and 49.05° (Table 1; entry 1, 3, 4, 9, 
and 12) were significantly decreased in the range of 12.46% 
to 16.63% compared with the control sample. Consequently, 
the crystallite size of the treated zinc chloride at 2θ equal to 
22.75°, 31.27°, 32.87°, 34.53°, 37.46°, 46.13, and 47.61, 
were increased in the range of 0.04% to 42.9% compared 
with the control sample (Table 1; entry 2, 5, 6, 7, 8, 10, and 
11). Overall, the average crystallite size of the treated sodium 
selenate was increased by 1.01% compared with the control 
sample. As per the literature, the increase in the lattice strain 
may reduce the crystallite size of the sample [45]. Therefore, 
it can be hypothesized that The Trivedi Effect® - Biofield 
Energy Treatment might induce some lattice strain within the 
treated molecules of sodium selenate, resulting in fracture of 
grains into sub-grains that could lead to the decrease in the 
crystallite size of the treated sample compared with the 
control sample. Alteration in crystallite size of the treated 
sample might have the influence on its solubility profile 
compared with the control sample. 
3.2. Particle Size Distribution (PSD) Analysis 
Particle sizes of the control and treated sodium selenate 
were investigated, and the results are presented in Table 2. It 
was observed that The Trivedi Effect® - Biofield Energy 
Treatment has significantly decreased the average particle 
size d10, d50, and d90 value of sodium selenate with respect to 
the control sample. The sizes at below 10% level (d10), 50% 
level (d50), and 90% level (d90) were decreased significantly 
by 6.14%, 16.56%, and 18.82%, respectively in the treated 
sample compared with the control sample. The control 
sample exhibited the surface area of 0.57m2/g and it was 
increased to 0.63 m2/g in the treated sodium selenate. The 
results indicated a significant increase in surface area by 
10.52% in the treated sample compared with the control 
sample. The particle size and the surface area have the major 
influence on solubility, absorption, dissolution, and 
bioavailability of the nutraceutical/pharmaceutical 
compounds [46]. The surface energy is the driving factor for 
dissolution efficiency and surface energy was mainly 
influenced by surface area and chemical affinity [47, 48]. 
Thus, it is predicted that The Trivedi Effect® - Biofield 
Energy Treated sodium selenate might be absorbed in faster 
rate from the gut and thus, can offer more bioavailability 
compared with the untreated sample. 
Table 2. Particle size data (d10, d50, and d90) and surface area of the control 
and Biofield Energy Treated sodium selenate.  
Test Item d10 (µm) d50 (µm) d90 (µm) Surface area (m
2/g) 
Control 4.428 18.876 58.456 0.57 
Biofield Energy
 
Treated 
4.156 15.751 47.455 0.63 
% Changea -6.14 -16.56 -18.82 10.52 
a denotes the percentage change in the particle size data (d10, d50, and d90) and 
surface area of Biofield Energy Treated sample with respect to the control 
sample. 
3.3. Fourier Transform Infrared (FT-IR) Spectroscopy 
The FT-IR spectra of the control and Biofield Energy 
Treated samples of sodium selenate are presented in Figure 2. 
The spectra showed the O-H stretching vibration at 3453cm-1 
and 3439 cm-1 and bending vibration at 1721cm-1 and 1723 
cm-1 in the control and treated samples, respectively. It is due 
to the water molecules, which are incorporated into the lattice 
structure of the crystalline inorganic compounds produced 
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the characteristic absorption bands [49, 50]. According to the 
literature, the FT-IR of metal oxide (i. e. Zn=O) shows the 
peak in the range of 1010-850 cm-1 (stretching) [51]. The 
spectra showed the sharp and strong peak at 888 cm-1 and 
887 cm-1 (Figure 2) due to the Se-O stretching in the 
fingerprint region for both the control and treated samples of 
sodium selenate, respectively. The fingerprint region of the 
treated sample was remained same as it was in the control 
sample. The analysis revealed that structure integrity of the 
treated sodium selenate remained unaffected with respect to 
the control sample. 
3.4. Ultra Violet-Visible (UV-Vis) Spectroscopy 
The UV-visible spectra of the control and treated samples 
(Figure 3) showed the maximum absorbance (λmax) at 204.8 
nm and 204.9 nm respectively, which showed a minor shift of 
absorbance maxima from 2.4626 in control to 2.5152 in the 
treated sample. The UV-visible absorbance occurred due to 
excitation of electrons from highest energy occupied 
molecular orbital (HOMO) to lowest energy unoccupied 
molecular orbital (LUMO) [52-54]. It indicated that the 
energy gap between the HOMO and LUMO in the treated 
sample was similar compared with the control sample. The 
UV-visible analysis exhibited no change in the λmax of the 
treated sodium selenate compared with the control sample. It 
is anticipated that the structural configuration of the sodium 
selenate remained unchanged due to The Trivedi Effect® - 
Biofield Energy Treatment. 
 
Figure 2. FT-IR spectra of the control and Biofield Energy Treated sodium selenate. 
3.5. Thermogravimetric Analysis (TGA) 
The TGA thermograms of the both control and treated 
samples and their thermal analysis data are shown in Figure 4 
and Table 3, respectively. The TGA thermograms of control 
and treated samples were exhibited two steps of thermal 
degradation. The control and treated samples had lost weight 
by 6.87% and 6.95%, respectively of their total original 
weight during the thermal degradation process. The total 
weight loss was slightly increased by 1.16% in the treated 
sodium selenate compared with the control sample. 
Table 3. Thermal degradation data of the control and Biofield Energy 
Treated sodium selenate.  
S. No. 
Temperature (oC) % Weight loss 
% Change 
Control Treated Control Treated 
1st step of degradation  101.01  104.45 0.14 0.14 0.00 
2nd step of degradation 896.18 896.04 6.73 6.81 1.19 
Total weight loss - - 6.87 6.95 1.16 
a denotes the percentage change in the weight loss of Biofield Energy 
Treated sample with respect to the control sample. 
3.6. Differential Scanning Calorimetry (DSC) Analysis 
Measurement of melting point and latent heat of fusion 
(∆H) of the control and treated samples of sodium selenate 
were performed using DSC analysis (Figure 5 and Table 4). 
The onset and endset temperatures of the control sample 
were 584.08 and 595.66°C, respectively, whereas these 
temperatures were found in the treated sample at 584.18 °C 
and 596.19°C, respectively. The melting point of the treated 
sodium selenate (588.69°C) was decreased slightly by 0.02% 
compared with the control sample (588.82°C). The latent 
heat of fusion was significantly increased by 6.37% in the 
treated sample (103.4 J/g) compared with the control sample 
(97.21 J/g). Thus, the treated sodium selenate needed more 
energy in the form of latent heat of fusion in order to undergo 
the process of melting after Biofield Energy Treatment [55]. 
It is hypothesized that the Biofield Energy Healing might 
induce the intermolecular force in the Biofield Energy 
Treated sodium selenate molecules, which possibly cause the 
elevation of the latent heat of fusion. 
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Figure 3. UV-vis spectra of the control and Biofield Energy Treated sodium selenate. 
 
Figure 4. TGA thermograms of the control and Biofield Energy Treated sodium selenate. 
 
Figure 5. DSC thermograms of the control and Biofield Energy Treated sodium selenate. 
Table 4. The latent heat of fusion (J/G) and melting point (°C) values of the control and Biofield Energy Treated sodium selenate.  
Sample Latent heat of fusion (∆H) J/g 
Onset melting temperature 
(Tonset) °C 
Peak melting temperature 
(Tpeak) °C 
Endset melting 
temperature (Tendset) °C 
Control  97.21 584.08 588.82 595.66 
Trivedi Effect® Treated 103.4 584.18 588.69 596.19 
% Changea 6.37 0.02 -0.02 0.09 
Tonset: Onset melting temperature, Tpeak: Peak melting temperature, Tendset: Endset melting temperature, ∆H: Latent heat of fusion, 
a denotes the percentage 
change of Biofield Energy Treated sample with respect to the control sample. 
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4. Conclusions 
The Trivedi Effect® - Energy of Consciousness (Biofield 
Energy Healing) has shown significant impact on the 
physicochemical and thermal properties of sodium selenate. 
The PXRD analysis of the treated sample showed the 
significant alteration of the crystallite size in the range of -
16.63% to 42.9% compared with the control sample. 
However, the average crystallite size of the treated sodium 
selenate was altered compared with the control sample. 
Particle size at d10, d50 and d90 was significantly decreased by 
6.14%, 16.56%, and 18.82%, respectively in the treated 
sample compared with the control sample. Consequently, the 
surface area of the treated sodium selenate was significantly 
increased by 10.52% compared with the control sample. The 
TGA analysis of the control and treated samples exhibited 
two steps of thermal degradation, and the total weight loss 
was increased by 1.16% in the treated sample compared with 
the control sample. The DSC analysis revealed a significant 
elevation of the latent heat of fusion (∆H) by 6.37% in the 
treated sodium selenate compared with the control sample. 
Therefore, the treated sodium selenate would be thermally 
more stable and advantageous in the long-term storage 
stability compared with the control sample. The Trivedi 
Effect® - Biofield Energy Healing Treatment has shown an 
impact on the reduction in the particle size, an increase in the 
surface area and increase in the latent heat of fusion of 
sodium selenate. Hence, The Trivedi Effect®, a new 
proprietary method that can be used to enhance the 
bioavailability of sodium selenate through changing the 
physicochemical and thermal properties. Thus, The Trivedi 
Effect® Energy Healing, could be a useful approach in the 
design of better nutraceutical and/or pharmaceutical 
formulations that can offer significant therapeutic responses 
against various diseases such as diabetes mellitus, allergies 
and septic shock; stress-related disorders like sleep disorder, 
insomnia, anxiety, depression, Attention Deficit Disorder 
(ADD), Attention Deficit Hyperactive Disorder (ADHD), 
mental restlessness (mind chattering), brain frog, low libido, 
impotency, lack of motivation, mood swings, fear of the 
future, confusion, migraines, headaches, forgetfulness, 
overwhelm, loneliness, worthlessness, indecisiveness, 
frustration, irritability, chronic fatigue, obsessive/compulsive 
behavior and panic attacks; inflammatory diseases and 
immunological disorders like Lupus, Systemic Lupus 
Erythematosus, Hashimoto Thyroiditis, Type 1. Diabetes, 
Asthma, Chronic peptic ulcers, Tuberculosis, Hepatitis, 
Chronic active hepatitis, Celiac Disease (gluten-sensitive 
enteropathy), Addison Disease, Crohn's disease, Graves’ 
Disease, Pernicious and Aplastic Anemia, Sjogren 
Syndrome, Irritable Bowel Syndrome (IBS), Multiple 
Sclerosis, Rheumatoid arthritis, Chronic periodontitis, 
Ulcerative colitis, Chronic sinusitis, Myasthenia Gravis, 
Atherosclerosis, Vasculitis, Dermatitis, Diverticulitis, 
Rheumatoid Arthritis, Reactive Arthritis, Alopecia Areata, 
Psoriasis, Scleroderma, Fibromyalgia, Chronic Fatigue 
Syndrome and Vitiligo; aging-related diseases like 
cardiovascular disease, arthritis, cancer, Alzheimer’s disease, 
dementia, cataracts, osteoporosis, diabetes, hypertension, 
glaucoma, hearing loss, Parkinson’s Disease, Huntington’s 
Disease, Prion Disease, Motor Neurone Disease, 
Spinocerebellar Ataxia, Spinal muscular atrophy, 
Amyotrophic lateral sclerosis, Friedreich’s Ataxia and Lewy 
Body Disease, chronic infections and much more. 
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